Intas gains exclusive commercialization rights for the Etanercept biosimilar, for more than 150 countries worldwide.This collaboration with mAbxience strengthens the…
The report features interviews of top Insurance Leaders, summarizing the impact of artificial intelligence in optimizing insurance sales & distribution.…